Sensyne Health Signs AI Research Pact With Roche
December 23 2019 - 5:31AM
Dow Jones News
By Ian Walker
Sensyne Health PLC (SENS.LN) said Monday that it has agreed to a
research project with Roche Holding AG (RO.EB) to apply artificial
intelligence for clinical trial design.
The British clinical AI technology company said the project will
initially focus on identifying patient populations in one disease
area and assessing and collating anonymized patient data with
anonymized electronic patient record information to support
clinical trial planning.
No financial terms were disclosed.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
December 23, 2019 05:16 ET (10:16 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024